Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Mol Biol Rep ; 45(6): 2631-2639, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30353476

RESUMEN

This work investigated the preventive effect of diphenyl diselenide [(PhSe)2] against the toxic effects of mercury in silver catfish (Rhamdia quelen). The animals were treated during 30 consecutive days with a (PhSe)2 supplemented feed (3.0 mg kg-1) or commercial feed. During the last 5 days the animals received a daily intraperitoneal dose of HgCl2 (1.7 mg kg-1) or Saline (0.9%). Twenty-four hours after the last HgCl2 injection, the animals were euthanized by spinal cord section to biological material obtainment. Hepatic (AST and ALT) and renal (ammonia and creatinine) toxicity biomarkers, δ-ALA-D activity, TBARS, total and non-protein thiols levels and hepatic, renal and blood mercury (Hg) and zinc (Zn) content were evaluated. Considering renal parameters, HgCl2 exposition increased serum creatinine levels and decreased δ-ALA-D activity, total and non-protein thiols and TBARS levels. HgCl2 exposure also decreased blood δ-ALA-D activity. With exception of blood δ-ALA-D activity and total thiols levels, (PhSe)2 supplementation partially prevented mercury induced alterations. Animals exposed to HgCl2 presented an increase in liver and kidney Hg content and a decrease in liver and blood Zn content. The alteration in blood Zn content was partially prevented with (PhSe)2 supplementation. With the exception of mercury and zinc content, no effects of HgCl2 exposure on hepatic tissue were observed. These results show that (PhSe)2 supplementation can represent a promising alternative to prevent the toxic effects presented by Hg exposure.


Asunto(s)
Derivados del Benceno/farmacología , Intoxicación por Mercurio/tratamiento farmacológico , Intoxicación por Mercurio/prevención & control , Compuestos de Organoselenio/farmacología , Animales , Derivados del Benceno/metabolismo , Bagres/metabolismo , Creatinina/sangre , Dieta , Suplementos Dietéticos , Femenino , Riñón/efectos de los fármacos , Hígado/efectos de los fármacos , Masculino , Cloruro de Mercurio/administración & dosificación , Mercurio/sangre , Intoxicación por Mercurio/sangre , Compuestos de Organoselenio/metabolismo , Compuestos de Sulfhidrilo/sangre , Zinc/sangre
2.
J Trace Elem Med Biol ; 29: 255-62, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24954677

RESUMEN

This work investigated the preventive effect of diphenyl diselenide [(PhSe)2] on renal and hepatic toxicity biomarkers and oxidative parameters in adult mice exposed to mercury chloride (HgCl2). Selenium (Se) and mercury (Hg) determination was also carried out. Mice received a daily oral dose of (PhSe)2 (5.0mg/kg/day) or canola oil for five consecutive days. During the following five days, the animals were treated with a daily subcutaneous dose of HgCl2 (5.0mg/kg/day) or saline (0.9%). Twenty-four hours after the last HgCl2 administration, the animals were sacrificed and biological material was obtained. Concerning toxicity biomarkers, Hg exposure inhibited blood δ-aminolevulinic acid dehydratase (δ-ALA-D), serum alanine aminotransferase (ALT) activity and also increased serum creatinine levels. (PhSe)2 partially prevented blood δ-ALA-D inhibition and totally prevented the serum creatinine increase. Regarding the oxidative parameters, Hg decreased kidney TBARS levels and increased kidney non-protein thiol levels, while (PhSe)2 pre-treatment partially protected the kidney thiol levels increase. Animals exposed to HgCl2 presented Hg content accumulation in blood, kidney and liver. The (PhSe)2 pre-treatment increased Hg accumulation in kidney and decreased in blood. These results show that (PhSe)2 can be efficient in protecting against these toxic effects presented by this Hg exposure model.


Asunto(s)
Derivados del Benceno/farmacología , Cloruro de Mercurio/toxicidad , Compuestos de Organoselenio/farmacología , Sustancias Protectoras/farmacología , Alanina Transaminasa/sangre , Animales , Aspartato Aminotransferasas/sangre , Creatinina/sangre , Riñón/efectos de los fármacos , Riñón/enzimología , Hígado/efectos de los fármacos , Hígado/enzimología , Masculino , Mercurio/sangre , Ratones , Porfobilinógeno Sintasa/sangre , Selenio/sangre , Compuestos de Sulfhidrilo/metabolismo , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , Urea/sangre
3.
Mol Cell Biochem ; 388(1-2): 277-86, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24370728

RESUMEN

Diabetes mellitus (DM) is associated with brain alterations that may contribute to cognitive dysfunctions. Chlorogenic acid (CGA) and caffeine (CA), abundant in coffee (CF), are natural compounds that have showed important actions in the brain. The present study aimed to evaluate the effect of CGA, CA, and CF on acetylcholinesterase (AChE), Na(+), K(+)-ATPase, aminolevulinate dehydratase (δ-ALA-D) activities and TBARS levels from cerebral cortex, as well as memory and anxiety in streptozotocin-induced diabetic rats. Animals were divided into eight groups (n = 5-10): control; control/CGA 5 mg/kg; control/CA 15 mg/kg; control/CF 0.5 g/kg; diabetic; diabetic/CGA 5 mg/kg; diabetic/CA 15 mg/kg; and diabetic/CF 0.5 g/kg. Our results demonstrated an increase in AChE activity and TBARS levels in cerebral cortex, while δ-ALA-D and Na(+), K(+)-ATPase activities were decreased in the diabetic rats when compared to control water group. Furthermore, a memory deficit and an increase in anxiety in diabetic rats were observed. The treatment with CGA and CA prevented the increase in AChE activity in diabetic rats when compared to the diabetic water group. CGA, CA, and CF intake partially prevented cerebral δ-ALA-D and Na(+), K(+)-ATPase activity decrease due to diabetes. Moreover, CGA prevented diabetes-induced TBARS production, improved memory, and decreased anxiety. In conclusion, among the compounds studied CGA proved to be a compound which acts better in the prevention of brain disorders promoted by DM.


Asunto(s)
Conducta Animal/efectos de los fármacos , Cafeína/farmacología , Ácido Clorogénico/farmacología , Café , Diabetes Mellitus Experimental/tratamiento farmacológico , Acetilcolinesterasa/biosíntesis , Animales , Ansiedad/tratamiento farmacológico , Peso Corporal/efectos de los fármacos , Corteza Cerebral/metabolismo , Masculino , Memoria/efectos de los fármacos , Trastornos de la Memoria/tratamiento farmacológico , Porfobilinógeno Sintasa/biosíntesis , Ratas , Ratas Wistar , ATPasa Intercambiadora de Sodio-Potasio/biosíntesis , Estreptozocina , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo
4.
Cell Biol Toxicol ; 28(4): 213-23, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22411701

RESUMEN

The aim of the present study was to evaluate the potential pharmacological and toxicological properties of (E)-1-(1-(methylthio)-1-(selenopheny) hept-1-en-2-yl) pyrrolidin-2-one (compound 1), an organoselenium compound. In vitro experiments showed that compound 1 presented a reduction in the lipid peroxidation induced by Fe²âº in thiobarbituric acid-reactive species (TBARS) production, and in the generation of reactive species caused by Fe²âº/malonate in DCFH-DA oxidation. The high dose (500 mg/kg) induced an increase on ALT but not on AST activity. Hepatic, but not cerebral, δ-ALA-D activity from mice treated with 500 mg/kg presented a significant inhibition. Brain catalase activity was significantly inhibited by 100 mg/kg whereas hepatic catalase activity showed a significant increase at all doses. Hepatic lipid peroxidation was diminished only at lowest dose (100 mg/kg) whereas for brain tissue, all doses induced a significant reduction in TBARS levels. Brain and liver ascorbic acid contents were increased only at highest dose of compound 1. Urea and creatinine levels were not significantly altered by treatments. This is a promising compound with antioxidant activity and low toxicity, suggesting the potential beneficial activity of compound 1 against oxidative damage in many parameters studied in rats and mice.


Asunto(s)
Antioxidantes/farmacología , Compuestos de Organoselenio/farmacología , Alanina Transaminasa/sangre , Análisis de Varianza , Animales , Antioxidantes/toxicidad , Ácido Ascórbico/metabolismo , Aspartato Aminotransferasas/sangre , Encéfalo/efectos de los fármacos , Encéfalo/enzimología , Catalasa/metabolismo , Creatinina/sangre , Compuestos Ferrosos/farmacología , Peroxidación de Lípido/efectos de los fármacos , Hígado/efectos de los fármacos , Hígado/enzimología , Masculino , Ratones , Compuestos de Organoselenio/toxicidad , Oxidantes/farmacología , Porfobilinógeno Sintasa/metabolismo , Ratas , Ratas Wistar , Especies Reactivas de Oxígeno/metabolismo , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , Extractos de Tejidos , Urea/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA